SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-08-182073
Filing Date
2008-08-21
Accepted
2008-08-21 13:24:20
Documents
4
Period of Report
2008-09-26
Effectiveness Date
2008-08-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 250830
2 GRAPHIC g71882g02u98.jpg GRAPHIC 10005
3 GRAPHIC g71882g07p20.jpg GRAPHIC 5075
4 GRAPHIC g71882g99t48.jpg GRAPHIC 7242
  Complete submission text file 0001193125-08-182073.txt   283776
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33004 | Film No.: 081031821
SIC: 2834 Pharmaceutical Preparations